7068287

AHR Monoclonal Antibody (4MEJJ), PE, eBioscience™, Invitrogen™

Rat Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

AHR

Concentration

0.2 mg/mL

Classification

Monoclonal

Form

Liquid

Regulatory Status

RUO

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Alias

Ah; Ah receptor; Ahh; Ahr; Ahre; AH-receptor; aromatic hydrocarbon receptor; aryl hydrocarbon receptor; aryl-hydrocarbon receptor; bHLHe76; Class E basic helix-loop-helix protein 76; dioxin receptor; In

Gene Symbols

AHR

Isotype

IgG2a κ

Purification Method

Affinity chromatography

Product Type

Antibody

Clone

4MEJJ

Applications

Flow Cytometry

Conjugate

PE

Host Species

Rat

Target Species

Mouse

Gene Accession No.

P30561

Gene ID (Entrez)

11622

Immunogen

E. coli derived, His-tagged AHR (aa 443-805)

Primary or Secondary

Primary

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Gene

AHR

Related Products

Img

Fischer Scientific

7068114

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068798

Rat Monoclonal Antibody...

Img

Fischer Scientific

7069213

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7068237

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068240

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068442

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068506

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068286

Rat Monoclonal Antibody...

Description

  • Description: This 4MEJJ monoclonal antibody recognizes mouse aryl hydrocarbon receptor (AHR)
  • The AHR is a ligand-activated transcription factor that mediates the toxic effects of a diverse group of environmental contamits, most notably aryl hydrocarbons such as polychlorinated biphenyls (PCB) and tetrachlorodibenzo-p-dioxin (TCDD)
  • The AHR has also been shown to bind to a number of naturally occurring compounds found in fruits and vegetables as well as compounds generated through normal cellular metabolism
  • AHR is localized in the cytoplasm in a complex that includes HSP90, p23, and XAP2/AIP/ARA9
  • Upon ligand-binding, AHR translocates to the nucleus and binds with aryl hydrocarbon receptor nuclear translocator (ARNT), and this complex binds to the consensus DNA sequence, GCGTG, found in the promoter/enhancer regions of many genes such as CYP1A1
  • The AHR is expressed in many cell types, with highest expression levels found in liver
  • The AHR has been shown to play a role in the regulation/differentiation of Treg and Th17 cells
  • The 4MEJJ monoclonal antibody has been found to recognize the b-1, b-2 and d alleles of mouse AHR but does not crossreact with human AHR
  • Applications Reported: This 4MEJJ antibody has been reported for use in intracellular staining followed by flow cytometric analysis
  • AHR (Ah Receptor) belongs to a family of proteins comprised of its dimerization partner ARNT (HIF-1 Beta) and the Drosophila proteins PER and SIM
  • AHR contains an N-terminal sequence of approximately 200 amino acids termed the PAS domain
  • AHR, found in a variety of tissues, binds to a specific DNA enhancer sequence and initiates transcription of the mRNA for the cytochrome P-450 (CYPIA1) gene
  • The gene for AHR encodes a ligand-activated transcription factor involved in the regulation of biological responses to planar aromatic hydrocarbons
  • AHR has been shown to regulate xenobiotic-metabolizing enzymes such as cytochrome P450, and its ligands included a variety of aromatic hydrocarbons
  • AHR is a ligand-activated helix/loop/helix transcription factor found in a variety of vertebrate species
  • The known ligands for AHR are foreign planar aromatic compounds, such as polycyclic aromatic compounds and halogenated aromatic compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
  • Unlike the steroid/thyroid hormone receptors, there is no known physiological ligand for AHR
  • Studies indicate that in non-ligand activated cells, AHR is found complexed with HSP90 predominantly in the cytoplasm
  • Upon binding to an agonist, the ligand-activated AhR is believed to transform to a nuclear, DNA binding form, and this transformation process appears to involve dissociation of HSP90 from AhR followed by formation of a heterodimer with AhR nuclear translocator protein (Arnt)
  • Diseases associated with AHR include eosinophilic fasciitis and seborrheic dermatitis.